Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2010
06/16/2010CN101743006A Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
06/16/2010CN101735201A Preparation method of piribedil
06/16/2010CN101735157A Preparation method of erlotinib hydrochloride
06/16/2010CN101735156A Poly-crystal L of erlotinib hydrochloride, preparation method and application thereof
06/16/2010CN101735155A Synthesis method of 2-pyrimidyloxyl benzyl substituted phenyl amine derivatives by using one-pot method
06/16/2010CN101735141A Hexa-aromatic heterocyclic diamine and preparation method thereof
06/16/2010CN101175732B Production method for quinazoline derivatives and its application for producing medicine used for treating tumor disease
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737274 reacting a methylester of N alpha -(2,6-dichlorobenzoyl)-4-amino-L-phenylalanine with 1,1'-carbonyldiimidazole or phenyl chloroformate as carbonyl group-Introducing reagents, then N-alkylating the intermediate formed with methyl p-toluenesulfonate to obtain quinazolinedione-phenylalanine derivatives
06/15/2010US7737159 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections
06/15/2010US7737157 such as 6-((2-(3-(dimethylamino)phenylamino)pyrimidin-4-yl)(methyl)amino)-N,2-dimethylbenzofuran-3-carboxamide, used for treating angiogenesis-related disorders selected from rheumatoid arthritis, age-related macular degeneration and psoriasis; inhibitors of kinase insert domain receptor (KDR)
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010CA2419875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/10/2010WO2010065586A2 Preparation of capecitabine
06/10/2010WO2010064737A1 Heterocyclic compound and use of the same
06/10/2010WO2010064688A1 Pyrimidine derivatives, horticultural insecticides comprising said derivatives and method of use thereof
06/10/2010WO2010032875A3 Heterocyclic carboxamide compounds
06/10/2010US20100144772 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
06/10/2010US20100144770 Pyrimidinones as Casein Kinase II (CK2) Modulators
06/10/2010US20100144765 5,6-trimethylenepyrimidin-4-one compounds
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144743 Compositions and methods for inhibition of tyrosine kinases
06/10/2010US20100144742 Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
06/10/2010US20100144741 Ethanolamine derivatives useful as bace inhibitors
06/10/2010US20100144732 Pyrimidine kinase inhibitors
06/10/2010US20100144731 Novel Biccyclic Compounds As GATA Modulators
06/10/2010US20100144722 Novel heterocyclic compounds as gata modulators
06/10/2010US20100144707 Pharmacokinetically improved compounds
06/10/2010US20100144706 Compounds
06/10/2010US20100143299 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
06/10/2010DE102008061214A1 Chinazolinamidderivate Chinazolinamidderivate
06/09/2010EP2194047A1 Preparation and use of aspartyl protease inhibitors
06/09/2010EP2193120A1 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3- alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides
06/09/2010EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
06/09/2010CN1784391B Quinazolines useful as modulators of ion channels
06/09/2010CN1735607B 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
06/09/2010CN101730686A Piperazine compounds with herbicidal action
06/09/2010CN101723906A Compound, medical composition containing same as well as preparation method and application
06/09/2010CN101723905A Synthesis method of 2-(2-(6-(2-cyano phenoxyl) pyridine-4-oxygroup) phenyl) methyl acetate
06/09/2010CN101723904A 4-cyano-diaryl pyridine derivatives as well as preparation methods and applications thereof
06/09/2010CN101723903A 4-carbonyl diaryl pyridine derivatives as well as preparation methods and applications thereof
06/09/2010CN101314594B Preparation method for 2-hydroxyl-5-fluorine pyrimidine
06/09/2010CN101177412B Method for synthesizing acetyl substituted nitrogen heterocycle compounds
06/09/2010CN101003511B Method for preparing 2 - amido - 4,6 - dichloro -formamido pyrimidines
06/08/2010US7732602 Herbicide composition
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732448 pesticides such as 4-(2-butynyloxy)-6-chloro-5-fluoropyrimidine, having an excellent ability to control pests
06/08/2010US7732444 4-{2-[4-(3-{[(3-Amino-propyl)-ethyl-amino]-methyl}-phenyl)-pyrimidin-2-ylamino]-ethyl}-phenol, used as protein kinase C inhibitors
06/08/2010US7731985 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2416442C Substituted 5-alkynyl pyrimidines having neurotrophic activity
06/03/2010WO2010061400A1 A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
06/03/2010WO2010061210A1 Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers
06/03/2010WO2010030891A3 Aryl guanidine f1f0-atpase inhibitors and related methods
06/03/2010WO2010013139A3 Radionuclide-labeled erlotinib
06/03/2010US20100137593 Crystals of phenylalanine derivatives and production methods thereof
06/03/2010US20100137592 Process for preparing purine derivative
06/03/2010US20100137586 Process for the Preparation of Gefitinib
06/03/2010US20100137566 Compounds and Methods Used to Treat Infectious Diseases
06/03/2010US20100137345 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
06/03/2010US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137323 Benzo-fused compounds for use in treating metabolic disorders
06/03/2010US20100137311 Substituted pyrimidine derivatives
06/03/2010US20100137304 Novel crystalline forms of the anti-cancer compound zd1839
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137250 Naphthylacetic acids
06/03/2010US20100136127 Solid preparation comprising alogliptin and metformin hydrochloride
06/03/2010US20100136116 Novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/03/2010CA2741928A1 Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers
06/03/2010CA2740977A1 A novel process for the preparation of lapatinib and its pharmaceutically acceptable salts
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
06/02/2010EP2190825A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
06/02/2010EP2190808A1 Leukotriene b4 inhibitors
06/02/2010EP2190287A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN1938280B Thiourea compositions and uses thereof
06/02/2010CN1840530B Process for preparing pemetrexed
06/02/2010CN101720318A Quinazolin-oxime derivatives as hsp90 inhibitors
06/02/2010CN101717371A Method for synthesizing 5-amino-6-cyano-2,4-dioxy hetero quinazoline derivatives
06/02/2010CN101717367A Preparation method of N, N'-dialkyl cyclic urea type derivative
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727986 Pesticide pyrimidinyloxy substituted phenylamidine derivatives
06/01/2010US7727417 Optically isotropic liquid crystal medium and optical device
06/01/2010CA2512305C A process for the production of 2,5-diamino-4,6-dichloropyrmidine
06/01/2010CA2367671C Process for the preparation of the polymorph a of doxazosin mesylate
05/2010
05/27/2010WO2010059773A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010WO2010059627A1 Polar quinazolines as liver x receptors ( lxrs ) modulators
05/27/2010WO2010059239A2 Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
05/27/2010WO2010058995A1 Electroluminescent device using the electroluminescent compounds
05/27/2010WO2010058417A1 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
05/27/2010WO2010058032A2 New compounds
05/27/2010WO2010058030A1 New compounds
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 427